HAEMONETICS CORPORATION (HAE) Net margin 2017–2026
HAEMONETICS CORPORATION (HAE) net profit margin by fiscal year — reported net income divided by reported revenue.
0.0%FY2026 · since FY2017: -3.0% → 0.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 0.0% | -0.0 pp |
| FY2025 | 0.0% | -9.0 pp |
| FY2024 | 9.0% | -0.9 pp |
| FY2023 | 9.9% | +5.5 pp |
| FY2022 | 4.4% | -4.8 pp |
| FY2021 | 9.1% | +1.4 pp |
| FY2020 | 7.7% | +2.1 pp |
| FY2019 | 5.7% | +0.6 pp |
| FY2018 | 5.0% | +8.0 pp |
| FY2017 | -3.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice